Preceptorship Programme 2023 is designed to enhance the knowledge of junior faculty, young doctors, trainees and new specialists with up-to-date clinical guidance. Using Evidence Based Medicine as a foundation of learning, the Experts will continue to focus on this objective of improving and updating young doctors on new techniques in treating common liver conditions. We will discuss complex liver cases to exemplify and obtain insights into their management.
The latest updates and training for the clinical management of liver diseases including Chronic Hepatitis B and C, NASH, HCC and other liver diseases.
How to interpret clinical data and manage complex liver disease cases.
Download sample Case Studies from 2022 Preceptee Winners
The applicant must:
The Expert Panel will make 2 selections:
All 2023 Preceptees will be given a SHC Grant totalling SGD600 to cover
The 2023 Preceptees who are selected to and present their Case Studies LIVE In Person at the end of the SHC Conference will be awarded prize of SGD400.
The Preceptorship Programme of the Singapore Hepatitis Conference is really a tremendous educative experience. The entire process of presenting our cases and the way in which the experts discussed and analyzed the cases was in itself, an enlightening process and provided us with newer insights. I hope this unique programme keeps inspiring and motivating many more young minds in the years to come.
SHC 2022, especially the preceptorship program, is the whole-package experience you will never want to miss. The speakers are all undoubtedly experts in hepatology; the topics are kept up-to-date; and the case discussions never stop to open your horizons. It was my second time attending SHC, and I will be delighted to attend the next one.
The SHC Hepatology Preceptorship program is an excellent platform for young gastroenterologists to learn important topics in hepatology as well as present their respective cases. What is unique to this event is its complexity and diversity because the cases are from different countries. We had the opportunity to communicate with our expert mentors right on the spot. They taught us how to approach each case based on recent evidence and from their personal experiences. I am looking forward to attending this event again next year.
“I am so grateful to participate in virtual SHC Preceptorship Programme 2022. This meeting provided a unique opportunity to be updated about Liver diseases in multidisciplinary point for views. Beside up-to-date guidelines, I had opportunity not only to share my case but also to understand experts thinking and solving in different interesting clinical cases. I have learnt many new things and believe it could be very useful in my daily practice. It’s my honor to recommend young Hepatology practitioners to take part in worthwhile SHC programme and hope to have a chance to attend again in near future. Thank you so much”
The following benefits are available to Young Doctors who have been accepted for the Preceptorship Programme.
Clinical Guidance
and Training
Opportunity to interact with internationally renowned experts
Experience making Oral Presentations to LIVE Audience in Person
If Your Case Study is selected for Preceptee Presentation, you will be given an additional award of SGD400.00
2023 Preceptees receive the SHC Grant to attend the Preceptorship Programme 2023 LIVE in Singapore
| Programme | Time (SGT) |
|---|---|
| Registration | 12:00 – 12:30 |
| Introduction & Evidence Based Hepatology (EBM) and Interpretation of the Medical Literature Prof Seng Gee Lim, National University of Singapore |
12:30 – 13:00 |
| Q & A | 13:00 – 13:10 |
| Diagnosis and Assessment of Abnormal Liver Function Tests – Dr Guan Huei Lee, National University Healthcare System |
13:10 – 13:30 |
| Case presentations Panelists: Prof. Chee Kiat Tan, Duke-NUS Medical School, Singapore and Dr Wei Peng Yong, Cancer Institute of Singapore View Bio (1) Hepatocholangiocarcinoma vs Atypical Hepatocellular Carcinoma (2) Chronic Hepatitis B infection (3) Not the Usual: Diagnostic Dilemma in a Case of a Large Well-Differentiated, Non-AFP Producing Hepatocellular Carcinoma with Atypical Features on Non-Invasive Imaging (4) Epithelioid hemangioendothelioma, a rare sarcoma of the liver |
13:30 – 14:10 |
| Tea Break | 14:10 – 14:30 |
| Is cirrhosis present? Diagnosis of cirrhosis, non invasive markers and when to biopsy – Dr Guan Huei Lee, National University Healthcare System |
14:30 – 14:50 |
| Case presentations Panelists: Professor Rajender Reddy, University of Pennsylvania and Dr Loey Mak, University of Hong Kong (1) Case of acute liver failure in a 7 month child – A diagnostic dilemma (2) ACLF secondary to DILI with underlying primary/secondary Hemachromatosis (3) Intermittent recurrent cholestatic disease (4) A case of acute fatty liver in pregnancy with newly diagnosed AIH (5) A patient with fulminant liver failure |
14:50 – 15:40 |
| Management of Focal liver lesions – Prof. Chee Kiat Tan, Duke-NUS Medical School, Singapore View Bio |
15:40 – 16:00 |
| Case presentations Panelists: Professor Guadalupe Garcia-Tsao, Yale School of Medicine & Dr Guan Huei Lee, National University Healthcare System (1) Evaluation of persistent jaundice in a young lady (2) Unexplained Transaminitis with significant weight loss (3) An Encounter with a Master Mimicker – case of presumed DILI secondary to antituberculosis medication turns out to have a revised diagnosis of sarcoidosis of the liver and lung. (4) Budd-chiari with Autoimmune Hepatitis : the odd blend (5) Upper and lower Gastrointestinal bleeding from esophageal varices, portal hypertensive gastropathy and portal hypertensive colopathy in decompensated liver cirrhosis complicated by hepatocellular carcinoma BCLC C |
16:00 – 16:50 |
| Closing and feedback | 16:50 – 17:00 |
| End of Programme | 17:15 |
